glp-1 for alcohol use disorder RAs may reduce alcohol-related hospitalization risk GLP-1 Drug Semaglutide Substantially Reduced
Description
Approximately 5% of individuals stopped taking the medication because of negative reactions, and easing symptoms may be achieved by slowly decreasing the dosage (Sanchez-Rangel and Inzucchi, 2017
We are working to ensure our patients have the best options available to them to preserve continuity of care
Medicina (B Aires)
According to the American Diabetes Association (ADA) Standards of Care, GLP-1 receptor agonists with proven cardiovascular benefit are recommended for many patients with type 2 diabetes who have established cardiovascular disease, with individualized therapy based on patient factors
